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Abstract 
Background: Although the optimal timing of initiation of renal replacement therapy (RRT) in critically ill patients 
with acute kidney injury has been extensively studied in the past, it is still unclear.
Methods: In this systematic review, we searched all related randomized controlled trials (RCTs) that directly com‑
pared earlier and later RRT published prior to June 25, 2016, from PubMed, MEDLINE, and EMBASE. We extracted the 
study characteristics and outcomes of all‑cause mortality, RRT dependence, and intensive care unit (ICU) and hospital 
length of stay (LOS).
Results: We identified 51 published relevant studies from 13,468 screened abstracts. Nine RCTs with 1627 partici‑
pants were included in this meta‑analysis. Earlier RRT was not associated with benefits in terms of mortality [rela‑
tive risk (RR) 0.88, 95% confidence interval (CI) 0.68–1.14, p = 0.33] and RRT dependence (RR 0.81, 95% CI 0.46–1.42, 
p = 0.46). There were also no significant differences in the ICU and hospital LOS between patients who underwent 
earlier versus later RRT [standard means difference −0.08 (95% CI −0.26 to 0.09) and −0.11 (95% CI −0.37 to 0.16) day, 
respectively]. In subgroup analysis, earlier RRT was associated with a reduction in the in‑hospital mortality among sur‑
gical patients (RR 0.78, 95% CI 0.64–0.96) and patients who underwent continuous renal replacement therapy (CRRT) 
(RR 0.80, 95% CI 0.67–0.96).
Conclusions: Compared with later RRT, earlier initiation of RRT did not show beneficial impacts on patient out‑
comes. However, a lower rate of death was observed among surgical patients and in those who underwent CRRT. The 
included literature is highly heterogeneous and, therefore, potentially subject to bias. Further high‑quality RCT studies 
are warranted.
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Background
Acute kidney injury (AKI) is a common yet potentially 
fatal complication of illnesses among 1% of the commu-
nity-based population, 8–15% of hospitalized patients, 
and up to 50% of critically ill patients admitted to the 
intensive care unit (ICU) [1–5]. AKI carries increased 
risk of morbidity and mortality and adds to the health-
care cost, even in mild temporary form [6–11].
Although renal replacement therapy (RRT) remains 
the primary supportive management strategy for patients 
with severe AKI, it could also be associated with com-
plications and adverse events [12–14]. Despite improve-
ments in RRT technology, it is still not clear whether 
the outcome of patients with AKI who require RRT has 
improved over the years [7, 15]. Earlier initiation of RRT 
may provide a better control of fluid and electrolyte bal-
ance, superior acid–base homeostasis, removal of ure-
mic waste, and prevention of subsequent complications 
attributable to AKI [16]. Furthermore, earlier RRT could 
potentially limit the kidney-specific and remote organ 
injuries due to fluid overload, electrolyte imbalance, and 
systemic inflammation [17]. However, earlier RRT may 
also expose the patients to increased risks of hemody-
namic instability, anticoagulation-induced bleeding, 
blood-stream infection, and even inflammatory or oxida-
tive stress induced by the bio-incompatibility of the dia-
lyzer membranes. In comparison, later initiation of RRT 
may allow more time for hemodynamic optimization 
prior to RRT, and it may avoid the need for RRT and its 
associated complications [18].
In recent decades, the timing of RRT initiation has 
been evaluated in different population types (e.g., surgi-
cal or medical patients). Variability in the definitions of 
AKI and RRT timing has resulted in contradicting con-
clusions among the various studies [19–23]. Similarly, 
previous systematic analyses regarding the optimal tim-
ing of RRT initiation were unable to draw definitive con-
clusions owing to the scarcity of large-scale randomized 
controlled trials (RCTs), non-standardized triggers for 
RRT initiation, and heterogeneities of population and 
study design. In summary, while the observational stud-
ies tended to show more beneficial effects for earlier 
RRT, clinical trials were unable to replicate these findings 
[24–27]. Recently, two large RCTs showed contradictory 
results and attracted considerable attention from both 
clinicians and researchers. The first was a multicenter 
RCT by the AKIKI study group [28], which showed no 
significant differences in 60-day mortality between early 
and delayed RRT groups. Another was the ELAIN trial, 
[29] a single-center RCT that showed significant ben-
efits in terms of 90-day mortality, renal function recov-
ery, and hospital length of stay (LOS) among patients in 
the early RRT group. Although these two RCTs exhibited 
opposing results, they added value to the field of critical 
care. This systematic review is conducted to include all 
relevant RCTs related to the impact of the timing of RRT 
initiation among critically ill patients with moderate to 
severe AKI.
Methods
Search strategy and selection criteria
In concordance with the Preferred Reporting Items 
for Systematic Reviews and Meta-analyses (PRISMA) 
guidelines, we conducted a systematic review and meta-
analysis to investigate the effect of earlier initiation of 
RRT on the outcomes of critically ill patients with AKI 
who require dialysis [30]. We searched MEDLINE, Pub-
Med, and EMBASE databases and identified the relevant 
articles published up to June 25, 2016, using Web of Sci-
ence. We screened references by titles and abstracts and 
included related studies for further analysis. Case reports 
or case series, non-English articles, articles not focused 
on critically ill patients, studies consisting of pediat-
ric patients, studies that did not present mortality data, 
and those that did not clearly define the timing of initia-
tion of RRT were excluded. The keywords used for data-
base search were provided in Additional file 1: Table S1. 
We only included studies with randomized controlled 
designs in the final meta-analysis. Both abstracts and full 
papers were selected for quality assessment and data syn-
theses. We contacted the authors of abstracts for further 
details, if available.
Data extraction and synthesis
We extracted data regarding the year of publication 
and patient enrollment, leading author, the number 
of patients, and events from each article. When avail-
able, odds ratios and 95% confidence intervals (CIs) from 
these RCTs were extracted. Other parameters for record 
included the type of patient setting (surgical/mixed/
medical), criteria used for AKI diagnosis, cohort size, 
presence of sepsis, study quality, and the proportions of 
patients on mechanical ventilation. Two researchers (TSL 
and CCH) independently extracted the data, and a third 
investigator (VCW) resolved any disagreements between 
them.
Risk of bias assessment
We assessed the risk of bias in the included articles 
using structured assessment tools. For RCTs, we use 
Cochrane review tools to access the risk of bias [31]. We 
evaluated the adequacy of randomization and conceal-
ment, blinding, reporting of outcomes, sample size cal-
culation, and disclosure of funding sources. We assessed 
the overall study quality according to current standards 
[31, 32].
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Definition of earlier versus later RRT initiation
The definition of earlier initiation of RRT varied substan-
tially among included RCTs. In four of the included tri-
als, initiation of RRT immediately after randomization 
was defined as “early” [28, 33–35]. In two studies, early 
initiation was considered when RRT started in less than 
12 h of admission to ICU, while in another study, authors 
used the serum BUN > 70 mg/dL or creatinine >7 mg/dL 
and the defining criteria for RRT initiation [36, 37]. One 
study compared prophylactic hemodialysis before sur-
gery with standard care [38]. In ELLAIN trial, early RRT 
was defined as initiation within 8 h of diagnosis of stage 2 
AKI using the KDIGO classification [29]. We included all 
definition of early dialysis based on each individual study 
design in order to evaluate the potential effect of early 
dialysis on the primary outcome; obviously, this leads to 
increased heterogeneity observed in our analysis.
Ascertainment of outcomes
The primary outcome of interest was all-cause mortality, 
including in-hospital mortality and 30-, 60-, and 90-day 
mortality. We also evaluated RRT dependence after hos-
pital discharge. The secondary outcomes were ICU or 
hospital LOS.
Statistical analyses
Owing to the significant heterogeneity among the 
enrolled studies, we used the random effects model. The 
overall summary risk ratios (RRs) and 95% CIs were cal-
culated using the Mantel–Haenszel method. We charac-
terized the heterogeneity with the I2 and τ2 statistic. A p 
value ≤0.05 was considered statistically significant. Sen-
sitivity analyses were conducted for variables that could 
modify the effect of initiation time and mortality. In sub-
group analysis, we performed meta-regression to assess 
the effect of interaction between variables and the tim-
ing of RRT initiation on mortality and RRT dependence. 
Funnel plots were drawn to evaluate the distribution of 
studies. Begg’s rank correlation test and Egger’s linear 
regression were used to assess the publication bias. We 
used STATA (version 13, Stata Corp. 2013. College Sta-
tion, TX: Stata Corp LP), and Review Manager (RevMan) 
(version 5.2. Copenhagen: The Nordic Cochrane Cen-




Figure 1 shows the flowchart of the literature search and 
selection process. We screened 13,468 abstracts, of which 
174 were eligible for full-text reviews. A total of 51 stud-
ies including 9 RCTs and 42 cohort studies presented 
data on the timing of RRT initiation among critically ill 
patients with AKI. These nine RCTs were included in 
the meta-analysis (Table 1). The trials were conducted in 
Europe, Asia, and Canada between 2002 and 2016.
A total of 1627 critically ill patients who underwent 
acute dialysis were enrolled in the final analysis. Seven 
of the nine studies provided quantifiable results for 
RRT dependence during the follow-up period. Four 
trials recruited surgical patients only, and two of them 
enrolled patients undergoing coronary bypass sur-
gery. The remaining five trials enrolled patients in the 
mixed surgical/medical ICU setting. Continuous renal 
replacement therapy (CRRT) was used as the modality 
of choice in five trials, and two trials used intermittent 
hemodialysis (IHD). The remaining studies utilized a 
mixture of the two dialysis modalities. Early high-vol-
ume hemofiltration was compared with the standard 
of care in one RCT. The quality of the included RCTs 
varied; most of the studies lacked sufficient informa-
tion regarding participants or personnel blinding and 
concealment processes (Additional file  1: Fig. S1). We 
divided these studies into high or low quality, with 3 out 
of 6 domains of bias as the cutoff for the quality assess-
ment tool. Publication bias was tested, and funnel plot 
was drawn. There was no obvious impact of study sam-
ple size with a p  =  0.846 for Egger’s test (Additional 
file 1: Fig. S2).
Primary outcomes
Among the included trials, the pooled mortality rates 
were 38.7% (309 of 798) and 42.5% (352 of 829) in the 
groups of patients who underwent earlier and later 
RRT, respectively. Pooled estimates of included stud-
ies indicated no significant survival benefit in patients 
who underwent earlier RRT compared with those who 
underwent later RRT, with an RR of 0.88 (95% CI 0.68–
1.14, p = 0.33) (Fig. 2). Substantial heterogeneity existed 
among studies, with an I2 value of 64.6%, and Chi-square 
p =  0.004. In addition, there were no significant differ-
ences in the 30-, 60-, and 90-day mortality between 
groups with earlier and later RRT (Fig. 3).
In the subgroup analyses, there were no differences 
between patients who underwent earlier and later RRT in 
the majority of subgroups, with three exceptions. Nota-
bly, earlier RRT seemed to provide a survival benefit in 
surgical patients (RR 0.78, 95% CI 0.64–0.95), but not in 
patients in the mixed ICUs (RR 1.00, 95% CI 0.87–1.16). 
This is despite the fact that we found no substantial evi-
dence of such differences when trials were stratified 
by the ICU setting (p  =  0.31 for interaction). Besides, 
the survival benefit of earlier RRT initiation was also 
observed in the patients who started with CRRT (RR 
0.80, 95% CI 0.66–0.95), but not in those who received 
mixed modalities (RR 1.01, 95% CI 0.86–1.17) or IHD 
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(RR 1.15, 95% CI 0.66–2.01) (p  =  0.43 for interaction) 
(Fig. 4; Additional file 1: Fig. S3).
Seven of the nine included RCTs reported information 
about RRT dependence. There was no statistically signifi-
cant difference in the risk of RRT dependence between 
patients with earlier and later initiation of RRT, with a 
pooled RR of 0.81 (95% CI 0.46–1.42) (Fig. 5). There was 
no evidence for heterogeneity with an I2 value = 0% and 
Chi-square p  =  0.748). In the subgroup analysis, there 
was no statistically significant difference in RRT depend-
ence across different subgroups (Additional file  1: Fig. 
S4).
Secondary outcomes
The mean weighted ICU LOS was 12.5  days (n  =  604) 
in the earlier RRT group and 13.0  days (n  =  614) in 
the later RRT group. The mean weighted hospital LOS 
was 29.4  days (n  =  604) in the earlier RRT group and 
31.3 days (n = 614) in the later RRT group. Pooled analy-
sis demonstrated no significant differences in the ICU 
LOS and hospital LOS between the two groups, with a 
standard difference in the means of −0.08  day (95% CI 
−0.26 to 0.09) and −0.11  day (95% CI −0.37 to 0.16), 
respectively (Additional file 1: Figs. S5, S6).
Fig. 1 Flowchart of study selection for meta‑analysis. RCT randomized controlled trials
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Discussion
In the current systematic review of nine RCT includ-
ing 1627 critically ill patients with AKI, who received 
RRT, we did not find any significant survival benefits in 
patients who underwent earlier versus later RRT. A con-
siderable heterogeneity across studies was observed. 
Furthermore, 30-, 60-, and 90-day mortality, dialysis 
dependence, and LOS in the hospital or ICU were not 
lower in patients who underwent earlier RRT in com-
parison with those who underwent later RRT. We noticed 
a lower mortality rate in the earlier RRT group only in 
postsurgical patients and among those who underwent 
CRRT.
In recent interventional studies, no survival benefits 
have been observed among different intensities [39] and 
modalities of dialysis [40]. The optimal timing of RRT ini-
tiation still remains debatable owing to the contradictory 
reports in the literature. To our knowledge, the current 
systematic review is the first to exclusively include most 
RCTs to address the issue of the timing of RRT initia-
tion and evaluate its impact on patient survival and RRT 
dependence (Table 2) [24–27, 41, 42].
Subgroup analyses
We hypothesized that using consensus AKI definitions, 
enrolling sepsis-associated AKI, differences in sample 
sizes and study qualities had high impacts on patient out-
comes observed among different investigations. When 
we used different AKI definitions, septic AKI, and study 
quality for subgroup analyses, we found no difference 
between earlier versus later RRT initiation time.
We found survival benefit for earlier RRT initiation 
when CRRT was utilized. Previous studies including one 
meta-analysis showed no difference in mortality or RRT 
dependence between various dialysis modalities [40, 43], 
while other meta-analyses showed that the use of CRRT 
decreases mortality or RRT dependence [42]. However, 
these findings largely were dependent on data from 
observational trials, which were potentially biased by 
allocation and the qualities were uncertain. Our analysis 
focused on RCTs, mostly with high qualities and appro-
priate randomization, and the results were more reliable. 
The possible mechanisms of the observed benefits from 
CRRT as the dialysis modality include gentler osmolar 
shifts, lower overall cumulative fluid balance, and clear-
ance of inflammatory factors [44]. Our study is not able 
Fig. 2 Forest plot for all‑cause mortality: all studies. RCT randomized controlled trials, RRT renal replacement therapy
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Fig. 3 Forest plots for mortality in a 30 days, b 60 days, and c 90 days
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to identify the reasons behind improved outcomes with 
CRRT, and further studies are warranted.
We also reported a survival benefit for postsurgi-
cal critically ill patients with AKI when they received 
“earlier” RRT. A meta-analysis showed that early initia-
tion of RRT for patients with AKI after cardiac surgery 
improved mortality [45]. Postoperative fluid overload in 
the surgical ICU is very common [46], and these patients 
may benefit from the earlier removal of excessive fluid 
by RRT [47, 48]. Other supporting evidence came from 
the observation that compared to patients admitted to 
medical ICU, those admitted to the surgical ICU admis-
sions at a greater risk for aggravation of cardiovascular, 
neurological, and respiratory diseases [49]. The literature 
review indicated that following initial resuscitation in the 
postsurgical critical care setting, maintaining appropri-
ate fluid balance through earlier RRT is clinically relevant 
[50]. Unlike surgical patients who often suffer from single 
organ failure, the heterogeneity of medical ICU patients 
may limit the effect of a single intervention (in this case 
“earlier” RRT). Additionally, many surgical patients who 
undergo elective surgeries have undergone extensive pre-
operative evaluation and optimization which contributed 
to their better outcomes in comparison with those of 
medical ICU patients [22].
In septic patients, earlier RRT was not found to be 
associated with improvement in mortality or RRT 
dependence. In this subgroup of patients, sepsis-associ-
ated AKI due to intrinsic renal lesions is only one part of 
the puzzle. Often, mortality in these patients correlates 
with various sepsis-induced inflammatory tissue dam-
ages and multi-organ failure [51]. Therefore, a single 
intervention may not be able to show a significant change 
in ICU outcomes, such as mortality. Furthermore, the 
possible adverse effects of earlier RRT such as enhanced 
clearance of antibiotics, amino acids and nutrients and 
hypothermia may counteract the benefits of a timely 
RRT. Moreover, in some studies, earlier initiation of RRT 
showed deleterious effects on the outcomes of patients 
with severe sepsis and septic shock; in addition, no differ-
ences were detected in their plasma cytokine levels [52]. 
Our results confirmed that earlier RRT initiation had 
Fig. 4 Forest plot for all‑cause mortality: in subgroups. RCT randomized controlled trials, RRT renal replacement therapy
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no beneficial effects on the clinical outcomes of patients 
with sepsis-related AKI.
There have been previous systematic reviews consist-
ing of a mixture of non-randomized cohort studies and 
a limited number of RCT regarding the optimal tim-
ing of RRT initiation [26, 27, 41, 42]. We were not able 
to confirm these reports in our systematic review. Previ-
ous studies concluded earlier RRT was associated with 
decreased mortality and RRT dependence in critically ill 
patients with AKI [26]. Contrary to the previous reports, 
we did not find a significant effect of earlier RRT on 
either ICU or hospital mortality and LOS, and dialysis 
dependence. In our study, only patients who underwent 
CRRT or postsurgical patients showed benefits in terms 
of the mortality rate for earlier RRT initiation.
One of the differences between the current study and 
previous reports was the inclusion of RCTs only, includ-
ing the two latest published RCT studies [28, 29], which 
accounted for the different results of our study from 
those of the previously studies [24, 26, 27, 41]. Prior 
meta-analyses that concluded survival benefit attributed 
to earlier RRT initiation relied heavily on data from ret-
rospective cohort studies that may possess incomplete 
pre-intervention data, preexisting significant differ-
ences among groups and heterogeneous study designs. 
Furthermore, observational studies are more subject to 
the selection bias when compared with RCTs.
As we showed, there is a significant heterogeneity 
among the studies related to the timing of RRT initia-
tion which may impact the results we found in this sys-
tematic analysis. There are some possible explanations 
for the discordance and heterogeneity among differ-
ent studies. Using varied definitions of AKI and differ-
ent AKI stage criteria for RRT initiation accounted for 
part of the observed heterogeneity. In the majority of 
previously reported cohort studies, the differences in 
pre-intervention study groups contributed to the hetero-
geneity of the results, making the systematic reviews dif-
ficult to interpret. Furthermore, “patients without RRT” 
were not used as “control” in cohort studies. As illus-
trated by the AKIKI trial [28], the mortality in patients 
in the “delayed RRT” arm who never underwent RRT was 
lower than the mortality of patients who actually under-
went RRT. Excluding patients who did not undergo RRT 
resulted in a significant bias. Another explanation is that 
compared with RCTs, observational studies (especially 
retrospective studies) are more subject to the selection 
bias. This highlights the critical need for a consensus 
definition of earlier versus later dialysis for the future 
studies and highlights the knowledge gap in the field. The 
Fig. 5 Forest plot for RRT dependence: all studies. RCT randomized controlled trials, RRT renal replacement therapy
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STARRT-AKI study, a 2015 pilot trial that evaluated the 
feasibility and safety of early versus standard timing for 
starting RRT, will provide more evidence about the opti-
mal timing of RRT initiation in AKI.
There are some limitations associated with our study. 
In our systematic review, we found no further informa-
tion regarding the other factors associated with mortal-
ity; therefore, we cannot comment on the differences 
in the outcomes on the basis of a single intervention, 
i.e., earlier or later RRT initiation. Furthermore, no trial 
standardized the dialysis modality or dose delivered dur-
ing RRT. We were not able to access the unpublished 
reports, which might have biased our results. Although 
our funnel meta-regression analysis showed a limited 
publication bias (Additional file 1: Fig. S2), the bias was 
always difficult to ascertain with a small sample number 
of the included studies. Finally, the definition of “ear-
lier” RRT was variable and may have unduly influenced 
pooled effect estimates. As defined by traditional mark-
ers, RRT was initiated relatively late which may influence 
the effectiveness of the early treatment. Furthermore, in 
the majority of the enrolled studies, clinical patient care 
is individualized based on the discretion of the clinician. 
This would add to the heterogeneity of the studies and 
their results.
The strength of our present analysis rested on our 
extensive literature search on RCTs. We used stand-
ard Cochrane protocols and had the largest cumulative 
RCT study sample size in comparison with the previous 
reports. We only focused on the RCTs that had a reason-
able quality with limited differential dropout based on 
the assigned treatment arm.
Conclusion
Compared to later initiation of RRT, earlier RRT initia-
tion in critically ill patients with AKI does not decrease 
mortality and long-term RRT dependence and does not 
alter the length of hospital stay. Earlier initiation of CRRT 
and earlier RRT in postsurgical patients may be associ-
ated with improved mortality. Future large-scale, mul-
ticenter, prospective interventional trials are needed to 
delineate the characteristics of patients who benefit from 
earlier initiation of RRT.
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